Your genetic makeup may play a bigger role in how well weight-loss medications work than previously thought. A new study of nearly 28,000 people found that specific genetic variations can predict both how much weight someone will lose on GLP-1 drugs and whether they're likely to experience nausea or vomiting .

How Do Genes Affect Weight-Loss Drug Response?

Researchers at 23AndMe, a DNA-testing service, analyzed data from users taking popular weight-loss medications and discovered that mutations in the GLP1R gene, which codes for the protein that these drugs target, directly influence how effective the medications are . The findings suggest that precision medicine, an approach tailored to individual genetic profiles, could soon transform obesity treatment.

The genetic effects were measurable but modest. People carrying one copy of the GLP1R variant lost an average of 1.7 pounds more over eight months of treatment compared to those without the variant. Those with two copies of the variant lost approximately 3.3 pounds more . While these differences might seem small, they could help doctors predict which patients will benefit most from these expensive medications.

Which Genes Predict Side Effects?

The research also identified genetic markers linked to medication-related nausea and vomiting, a common reason people stop taking weight-loss drugs. Mutations in two genes, GLP1R and GIPR (which relates to insulin secretion and energy production), were associated with increased side effects .

The GIPR variant showed particularly striking results for people taking tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity. Those carrying the variant were 83% more likely to vomit after taking tirzepatide compared to non-carriers . This kind of genetic insight could help doctors choose which medication to prescribe based on a patient's individual risk profile.

Steps to Understanding Your Genetic Response to Weight-Loss Medications

• Genetic Testing: Ask your doctor whether genetic testing for GLP1R and GIPR variants might be helpful before starting weight-loss medications, especially if you have concerns about side effects or want to predict treatment effectiveness.
• Medication Selection: Share your genetic results with your healthcare provider to help determine which GLP-1 drug or alternative medication might work best for your individual biology and minimize unwanted side effects.
• Dosage Planning: Discuss with your doctor whether your genetic profile suggests starting at a lower dose to reduce nausea risk, or whether a higher dose might be needed to achieve meaningful weight loss.

The researchers acknowledged that the genetic effect on weight loss was relatively small, but they emphasized the broader significance of their findings. "These findings provide direct genetic evidence that variation in the drug-target genes contributes to inter-person variability in response and lay the foundation for precision medicine approaches in the treatment of obesity," they stated in their Nature publication .

What Does This Mean for the Future of Obesity Treatment?

This research represents a shift toward personalized medicine in obesity care. Rather than prescribing the same medication at the same dose to everyone, doctors could eventually use genetic information to tailor treatment plans. Some patients might benefit from higher doses, while others might need different medications altogether to avoid side effects .

The study also highlights how much we still have to learn about why people respond differently to the same medications. Genetic variations account for some of this difference, but other factors, including diet, exercise, metabolism, and overall health, also play important roles. The findings suggest that a one-size-fits-all approach to weight-loss medication may be outdated.

As GLP-1 drugs continue to gain popularity for weight loss and diabetes management, understanding individual genetic responses becomes increasingly important. This research could help millions of people find the right medication and dose for their unique biology, potentially improving outcomes and reducing the frustration of side effects or inadequate weight loss.